Stevanato Group Q2 Earnings Call Highlights
Kort samengevat
Stevanato Group (NYSE:STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its full-year outlook to reflect the divestiture of its California-based Balda C. Brewer subsidiary. Revenue for the quarter reached €302 million, up 8% both on a reported and constant-currency […]
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Ticker Report.
Lees het volledige bericht ↗